Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-5230

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-5230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5230 1)

Label for Ondansetron ODT 8 mg orally disintegrating tablets, package of 10 tablets, from NuCare Pharmaceuticals, Inc. The label includes NDC 68071-5230-1, manufacturer information (Sun Pharmaceutical Industries Ltd., India), barcode, patient instructions (dose frequency and administration times), and warnings to keep out of reach of children and store at 68-77°F.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of ondansetron hydrochloride dihydrate, showing the molecular rings and side groups characteristic of this active ingredient form.*

FDA Label Image

Spl-ondansetron-chemical-structure (Spl Ondansetron Chemical Structure)

Chemical structure diagram of ondansetron, illustrating its molecular framework with rings and functional groups as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.